Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | TSPO | P30536 | 1/20 | 0.39 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.39 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29204584 | 0.84 | OPRM1 (0.44) | — | |
| SCHEMBL28431105 | 0.84 | MMP2 (0.45) | MEN1KMT2AALDH1A1KDM4ELMNA | |
| SCHEMBL3022089 | 0.84 | ALDH1A1 (0.40) | MEN1KMT2AALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL28432352 | 0.84 | ALDH1A1 (0.40) | MEN1KMT2AALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL10537885 | 0.83 | KEAP1 (0.51) | MEN1KMT2AALDH1A1SMN1; SMN2TSPO | |
| SCHEMBL6511106 | 0.83 | ALDH1A1 (0.50) | MEN1KMT2AALDH1A1SMN1; SMN2TSPO | |
| SCHEMBL16494644 | 0.81 | TSPO (0.49) | KMT2AALDH1A1RAB9ASMN1; SMN2TSPO | |
| SCHEMBL10282142 | 0.79 | ALDH1A1 (0.48) | MEN1KMT2AALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL4036462 | 0.77 | SMN1; SMN2 (0.49) | MEN1KMT2AALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL27406330 | 0.76 | ALDH1A1 (0.31) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113423742-B | Bis (arylphenoxide) lewis base catalysts and methods thereof | 埃克森美孚化学专利公司 | 2023-05-05 | — | — | CN | disclosed |
| EP-3924395-A1 | B!S(ARYL PHENOLATE) LEWIS BASE CATALYSTS AND METHODS THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2021-12-22 | — | — | EP | disclosed |
| US-11203654-B2 | Bis(aryl phenolate) lewis base catalysts and methods thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2021-12-21 | — | — | US | disclosed |
| US-11203654-B2 | Bis(aryl phenolate) lewis base catalysts and methods thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2021-12-21 | — | — | US | disclosed |
| CN-109081800-B | Containing CF3Synthesis method of indoline and 1,2,3,4-tetrahydroisoquinoline | 昆明学院 | 2021-10-01 | — | — | CN | disclosed |
| CN-113423742-A | Bis (arylphenolate) lewis base catalysts and processes thereof | 埃克森美孚化学专利公司 | 2021-09-21 | — | — | CN | disclosed |
| WO-2020167824-A1 | B!S(ARYL PHENOLATE) LEWIS BASE CATALYSTS AND METHODS THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-08-20 | — | — | WO | disclosed |
| WO-2020167824-A1 | B!S(ARYL PHENOLATE) LEWIS BASE CATALYSTS AND METHODS THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-08-20 | — | — | WO | disclosed |
| US-20200254431-A1 | BIS(ARYL PHENOLATE) LEWIS BASE CATALYSTS AND METHODS THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. | 2020-08-13 | — | — | US | disclosed |
| US-20200254431-A1 | BIS(ARYL PHENOLATE) LEWIS BASE CATALYSTS AND METHODS THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. | 2020-08-13 | — | — | US | disclosed |
| US-20110080458-A1 | NOVEL DYES AND USE THEREOF IN IMAGING MEMBERS AND METHODS | ZINK IMAGING, INC. | 2011-04-07 | — | — | US | disclosed |
| US-7704667-B2 | Dyes and use thereof in imaging members and methods | ZINK IMAGING, INC. (US) | 2010-04-27 | — | — | US | disclosed |
| WO-2009097433-A1 | NOVEL DYES AND USE THEREOF IN IMAGING MEMBERS AND METHODS | ZINK IMAGING, INC. (US) | 2009-08-06 | — | — | WO | disclosed |
| US-20080187866-A1 | NOVEL DYES AND USE THEREOF IN IMAGING MEMBERS AND METHODS | ZINK IMAGING, LLC | 2008-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11203654-B2 | Bis(aryl phenolate) lewis base catalysts and methods thereof | PHKB, TYR, ELL | MEN1 4810/4885KMT2A 1420/4885ALDH1A1 1743/4885 |
| US-20080187866-A1 | NOVEL DYES AND USE THEREOF IN IMAGING MEMBERS AND METHODS | CACYBP, KLHDC2, ZKSCAN2 | MEN1 2192/4885KMT2A 4563/4885ALDH1A1 3328/4885 |
| US-20110080458-A1 | NOVEL DYES AND USE THEREOF IN IMAGING MEMBERS AND METHODS | CACYBP, KLHDC2, ZKSCAN2 | MEN1 2192/4885KMT2A 4563/4885ALDH1A1 3328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.